Glenview / Rockville / San Antonio / Newark / New York / Washington / DC / Philadelphia / Los Angeles / Lausanne / Washington / New York City / Chicago / /
Company
Merck Research Laboratories / GE / Tennant / /
Country
Switzerland / United States / Australia / /
Currency
pence / USD / /
Event
Product Issues / Product Recall / /
Facility
Arch Gen Psychiatry / University of Michigan Institute / Sinai Narcotics Rehabilitation Center / Whitehouse Station / /
IndustryTerm
reluctant insurance / chemical composition / diagnostic tool / /
MedicalCondition
persistent drug abuse / continued heroin abuse / JE / HIV / flu / abstinence syndrome / severe withdrawal symptoms / precipitate abstinence syndrome / chronic use / hepatitis C / organ dysfunction / subjective withdrawal symptoms / kidney disease / soon developed withdrawal symptoms / narcotic addiction / reported withdrawal symptoms / unnecessary abstinence syndrome / chronic medical condition / drug abuse / widespread infectious diseases / HIV/AIDS / withdrawal symptoms / tuberculosis / /
MedicalTreatment
antibiotics / psychotherapy / pharmacotherapy / /
Organization
Center for Substance Abuse Treatment / U.S. Department of Health and Human Services / the University of Michigan Institute for Social Research / American Society of Addiction Medicine / U.S. Department of Justice / office of National Drug Control Policy / 4Mount Sinai Narcotics Rehabilitation Center / Center for Addictive Problems / U.S. Drug Enforcement Agency / Society for Neuroscience / Drug Enforcement Administration / /
Person
CHIN B. EAP / Vincent Dole / MARC SHINDERMAN / Dea P. Domestic / Andrew Byrne / Chevy Chase / Herman Joseph / PHILIP PARIS / J. Thomas Payte / SARZ MAXWELL / /
When “Enough” Is Not Enough: New Perspectives on Optimal Methadone Maintenance Dose STEWART B. LEAVITT, PH.D.1, MARC SHINDERMAN, M.D.2, SARZ MAXWELL, M.D.2, CHIN B. EAP, PH.D.3, AND PHILIP PARIS, M.D.4 Abstract